Opportunities Assessment for Diabetes Therapeutics - AustraliaFrost & SullivanDecember 23, 2008 53 Pages - SKU: MC2199600 |
|
Freedonia Focus on Diabetes Monitoring Products: United States
5/31/2012 | published by: Freedonia Focus
This report discusses US demand for diabetes monitoring products for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size, product and market segmentation, regulatory considerations, product development, market environment, product
|
more...
|
$600.00
|
|
Targeted Health and Wellness Foods and Beverages: The U.S. Market and Global Trends
3/1/2012 | published by: Packaged Facts
The market for targeted health and wellness foods and beverages is a dynamic and promising one, driven largely by the growing recognition—among scientists, government, practitioners, and consumers alike—of the instrumental role diet plays in a
|
more...
|
$3,500.00
|
|
Diabetic Retinopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Diabetic Retinopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2012 provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Anti-Diabetic Pharmaceuticals Market in India 2012
3/30/2012 | published by: Netscribes (India) Pvt. Ltd.
Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world after China, the Indian market is characterized by
|
more...
|
$795.00
|
|
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
2/29/2012 | published by: GlobalData
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report
|
more...
|
$6,995.00
|
|
Diabetic Foot Ulcers – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Diabetic Foot Ulcers – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Diabetic Foot Ulcers - Pipeline Review, H1 2012', provides an overview of the Diabetic Foot Ulcers therapeutic pipeline. This report provides information on the therapeutic
|
more...
|
$500.00
|
|
Diabetes – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Diabetes – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Diabetes - Pipeline Review, H1 2012', provides an overview of the Diabetes therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest
|
more...
|
$500.00
|
|
Diabetic Nephropathy – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Diabetic Nephropathy – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Diabetic Nephropathy - Pipeline Review, H1 2012', provides an overview of the Diabetic Nephropathy therapeutic pipeline. This report provides information on the therapeutic development for Diabetic
|
more...
|
$500.00
|
|
Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists
2/29/2012 | published by: GBI Research
Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists Summary GBI Research, the leading business intelligence provider, has released its
|
more...
|
$3,500.00
|
|
Global Continuous Glucose Monitoring Device Market 2011-2015
4/6/2012 | published by: Infiniti Research Limited
TechNavio’s analysts forecast the the Global Continuous Glucose Monitoring Device market to grow at a CAGR of 11.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is worldwide
|
more...
|
$1,500.00
|
